197 related articles for article (PubMed ID: 8077184)
21. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease.
Kirby DM; Boneh A; Chow CW; Ohtake A; Ryan MT; Thyagarajan D; Thorburn DR
Ann Neurol; 2003 Oct; 54(4):473-8. PubMed ID: 14520659
[TBL] [Abstract][Full Text] [Related]
22. Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion.
Porteous WK; James AM; Sheard PW; Porteous CM; Packer MA; Hyslop SJ; Melton JV; Pang CY; Wei YH; Murphy MP
Eur J Biochem; 1998 Oct; 257(1):192-201. PubMed ID: 9799119
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of mitochondrial diseases.
Ylikallio E; Suomalainen A
Ann Med; 2012 Feb; 44(1):41-59. PubMed ID: 21806499
[TBL] [Abstract][Full Text] [Related]
24. Ocular histopathologic study of a patient with the T 8993-G point mutation in Leigh's syndrome.
Hayashi N; Geraghty MT; Green WR
Ophthalmology; 2000 Jul; 107(7):1397-402. PubMed ID: 10889120
[TBL] [Abstract][Full Text] [Related]
25. Leigh-type neuropathology in Pearson syndrome associated with impaired ATP production and a novel mtDNA deletion.
Santorelli FM; Barmada MA; Pons R; Zhang LL; DiMauro S
Neurology; 1996 Nov; 47(5):1320-3. PubMed ID: 8909450
[TBL] [Abstract][Full Text] [Related]
26. USMG5 Ashkenazi Jewish founder mutation impairs mitochondrial complex V dimerization and ATP synthesis.
Barca E; Ganetzky RD; Potluri P; Juanola-Falgarona M; Gai X; Li D; Jalas C; Hirsch Y; Emmanuele V; Tadesse S; Ziosi M; Akman HO; Chung WK; Tanji K; McCormick EM; Place E; Consugar M; Pierce EA; Hakonarson H; Wallace DC; Hirano M; Falk MJ
Hum Mol Genet; 2018 Oct; 27(19):3305-3312. PubMed ID: 29917077
[TBL] [Abstract][Full Text] [Related]
27. [Diseases of mitochondrial DNA].
Montoya J; Playán A; Solano A; Alcaine MJ; López-Pérez MJ; Pérez-Martos A
Rev Neurol; 2000 Aug 16-31; 31(4):324-33. PubMed ID: 11008288
[TBL] [Abstract][Full Text] [Related]
28. Nuclear gene defects in mitochondrial disorders.
Zeviani M; Corona P; Nijtmans L; Tiranti V
Ital J Neurol Sci; 1999 Dec; 20(6):401-8. PubMed ID: 10937860
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the Bioenergetics Health Index Ratio in Leigh Syndrome Fibroblasts to Understand Disease Severity.
Bakare AB; Dean J; Chen Q; Thorat V; Huang Y; LaFramboise T; Lesnefsky EJ; Iyer S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638685
[TBL] [Abstract][Full Text] [Related]
30. Nuclear DNA origin of cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence based on patient's-derived rho degrees transformants.
Tiranti V; Munaro M; Sandonà D; Lamantea E; Rimoldi M; DiDonato S; Bisson R; Zeviani M
Hum Mol Genet; 1995 Nov; 4(11):2017-23. PubMed ID: 8589677
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial genetics and human disease.
Grossman LI; Shoubridge EA
Bioessays; 1996 Dec; 18(12):983-91. PubMed ID: 8976155
[TBL] [Abstract][Full Text] [Related]
32. Deficiency of the adenine nucleotide translocator in muscle of a patient with myopathy and lactic acidosis: a new mitochondrial defect.
Bakker HD; Scholte HR; Van den Bogert C; Ruitenbeek W; Jeneson JA; Wanders RJ; Abeling NG; Dorland B; Sengers RC; Van Gennip AH
Pediatr Res; 1993 Apr; 33(4 Pt 1):412-7. PubMed ID: 8479824
[TBL] [Abstract][Full Text] [Related]
33. Clinical features associated with the A-->G transition at nucleotide 8344 of mtDNA ("MERRF mutation").
Silvestri G; Ciafaloni E; Santorelli FM; Shanske S; Servidei S; Graf WD; Sumi M; DiMauro S
Neurology; 1993 Jun; 43(6):1200-6. PubMed ID: 8170567
[TBL] [Abstract][Full Text] [Related]
34. NDUFA10 mutations cause complex I deficiency in a patient with Leigh disease.
Hoefs SJ; van Spronsen FJ; Lenssen EW; Nijtmans LG; Rodenburg RJ; Smeitink JA; van den Heuvel LP
Eur J Hum Genet; 2011 Mar; 19(3):270-4. PubMed ID: 21150889
[TBL] [Abstract][Full Text] [Related]
35. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome.
Santorelli FM; Shanske S; Macaya A; DeVivo DC; DiMauro S
Ann Neurol; 1993 Dec; 34(6):827-34. PubMed ID: 8250532
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biochemical characteristics in patients with a high mutant load of the mitochondrial T8993G/C mutations.
Morava E; Rodenburg RJ; Hol F; de Vries M; Janssen A; van den Heuvel L; Nijtmans L; Smeitink J
Am J Med Genet A; 2006 Apr; 140(8):863-8. PubMed ID: 16532470
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial DNA mutations in diseases of energy metabolism.
Wallace DC
J Bioenerg Biomembr; 1994 Jun; 26(3):241-50. PubMed ID: 8077179
[TBL] [Abstract][Full Text] [Related]
38. Human NARP mitochondrial mutation metabolism corrected with alpha-ketoglutarate/aspartate: a potential new therapy.
Sgarbi G; Casalena GA; Baracca A; Lenaz G; DiMauro S; Solaini G
Arch Neurol; 2009 Aug; 66(8):951-7. PubMed ID: 19667215
[TBL] [Abstract][Full Text] [Related]
39. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome.
de Vries DD; van Engelen BG; Gabreëls FJ; Ruitenbeek W; van Oost BA
Ann Neurol; 1993 Sep; 34(3):410-2. PubMed ID: 8395787
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of mitochondrial myopathies.
Milone M; Wong LJ
Mol Genet Metab; 2013; 110(1-2):35-41. PubMed ID: 23911206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
